Allergen immunotherapy: current and new therapeutic strategies. - Wikidata - wikimedia - TriplyDB

Allergen immunotherapy: current and new therapeutic strategies.

Allergen immunotherapy: current and new therapeutic strategies.

http://www.wikidata.org/entity/Q34074753

about

A human dendritic cell-based method to identify CD4+ T-cell epitopes in potential protein allergens A DNA vaccine encoding a chimeric allergen derived from major group 1 allergens of dust mite can be used for specific immunotherapy.Lead identification and structure-activity relationships of heteroarylpyrazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists.Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals.A battery of genotoxicity studies with an allergy vaccine adjuvanted with monophosphoryl lipid A (MPL®) for the treatment of grass pollen allergy.Hypoallergenic derivatives of major grass pollen allergens for allergy vaccination.Induction of immune tolerance in asthmatic mice by vaccination with DNA encoding an allergen-cytotoxic T lymphocyte-associated antigen 4 combination.Specific allergen immunotherapy: time for alternatives?

P2860

Q24813625-D5186ED8-9136-48E8-9354-C95F57E1AF99 Q34371132-959693F9-A211-4640-9491-B91BB812EBCB Q35090956-8C621FE3-D2AB-4776-9331-F9108C5B30F9 Q36653972-B1DEE5A2-60ED-4284-A7AA-23C4076E7EA0 Q39259292-A98C7760-6598-48BF-B7A2-2BC8855891F0 Q40567247-33C0D6A7-4056-4377-8AF4-D1FC73D690A3 Q41868879-E79F8B9F-6863-43D4-88AC-E317F6516CF0 Q53729000-88390BDD-D3FE-4AB5-8BA6-510B82E852B8

P2860

Allergen immunotherapy: current and new therapeutic strategies.

http://www.wikidata.org/entity/Q34074753

description

2000 nî lūn-bûn

@nan

2000 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի մարտին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

name

Allergen immunotherapy: current and new therapeutic strategies.

@ast

Allergen immunotherapy: current and new therapeutic strategies.

@en

Allergen immunotherapy: current and new therapeutic strategies.

@nl

type

label

Allergen immunotherapy: current and new therapeutic strategies.

@ast

Allergen immunotherapy: current and new therapeutic strategies.

@en

Allergen immunotherapy: current and new therapeutic strategies.

@nl

prefLabel

Allergen immunotherapy: current and new therapeutic strategies.

@ast

Allergen immunotherapy: current and new therapeutic strategies.

@en

Allergen immunotherapy: current and new therapeutic strategies.

@nl

P1433

Q34074753-8D6228A2-E6B8-4894-8117-FB7C094612BC

P1476

Q34074753-00588BF1-03F6-4564-95FF-C632EF085ED3

P2093

Q34074753-289653FD-1EFF-4A72-8412-59B399A1BD6C

Q34074753-4F0BB6CD-EB83-46C7-8431-F80BDEAC0557

Q34074753-DF1125C8-33BD-41F9-8BF3-704BC974F75C

P2860

Q34074753-0042D8FE-4AD9-4EA5-9FF1-2B949B92257E

Q34074753-0CB0CC8D-5E62-406F-8D14-6B4FEDBDD0F7

Q34074753-1398319B-690D-42EE-93C4-D2908C959BBE

Q34074753-1BF02ADD-5F46-4680-89B9-BDFA3947C94C

Q34074753-1F96DD50-1A81-47E6-97CD-5CCB2FA07A44

Q34074753-29BE2F34-0DF8-4630-BC07-E2E6ADAE5D96

Q34074753-303DCCFF-4F85-4391-907E-8DD90BB350A3

Q34074753-335BCA16-9265-478A-9775-C68F16F4FFDF

Q34074753-35B098D3-B530-41DB-A406-D307B51FC2BC

Q34074753-3AA8E93D-D811-4242-A5D3-229E93D7FCDE

P304

Q34074753-C137B078-E12A-41B6-A661-383013A76C61

P31

Q34074753-AF0EB07A-F6A6-4CE9-A379-F7E2C1582E00

P356

Q34074753-D8EFD7A3-CD80-44CF-B103-1074654970C7

P407

Q34074753-7914AA04-2BE6-4E11-B4D8-50D502D605EB

P433

Q34074753-DF223293-3836-4EC7-89C0-6C5C9F759CC3

P478

Q34074753-EE22438A-FB2A-4320-933F-B997724AB790

P577

Q34074753-57670DC7-1D54-4144-9523-55EDAFC3CF4E

P5875

Q34074753-AAF80157-E85A-4F15-8542-AB9300A181C2

P698

Q34074753-2566F5B1-3E80-4C83-9924-3472C50B039F

P921

Q34074753-0B587282-CA28-464B-9B5A-CC217F84164A

P356

13543784.9.3.515

P1433

Expert Opinion on Investigational Drugs

P1476

Allergen immunotherapy: current and new therapeutic strategies.

@en

P2093

Douglass J

http://www.w3.org/2001/XMLSchema#string

O'Hehir RE

http://www.w3.org/2001/XMLSchema#string

Rolland JM

http://www.w3.org/2001/XMLSchema#string

P2860

Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party

Recombinant allergens for immunotherapy: a Der p 2 variant with reduced IgE reactivity retains T-cell epitopes.

Engineering of hypoallergenic mutants of the Brassica pollen allergen, Bra r 1, for immunotherapy.

Long-term clinical efficacy of grass-pollen immunotherapy.

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

The specificity and regulation of T-cell responsiveness to allergens.

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.

Identification, cloning, and sequence of a major allergen (Hev b 5) from natural rubber latex (Hevea brasiliensis).

Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system

P304

515-527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.9.3.515

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2000-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12265616

http://www.w3.org/2001/XMLSchema#string

P698

11060692

http://www.w3.org/2001/XMLSchema#string

P921